【摘要】 作为工程学理念介入生命科学的典型代表，合成生物学正重塑全球生物安全格局与伦理边界。然而，技术的快速演进暴露出现有国际硬法体系在规范涵摄力、适用外延及跨体系协调方面的制度局限性。与此同时，国际软法凭借动态适应性、主体包容性及跨领域协同优势，逐渐成为应对新兴技术不确定性与伦理冲突的重要机制。以国际组织、科研共同体及行业协会为核心的多元主体，正通过出台伦理准则、技术标准及最佳实践规范，构建起多维度的软法治理网络，有效支撑风险预警、技术分级与研发行为的规范化。未来的技术治理逻辑应确立软硬法协同的动态耦合，即以软法承担规则探索与前瞻引导的适应性规则供给，以硬法锚定并强制实施底线义务。通过推进这一协同路径，促进规范体系的整合与治理范式的更新，从而保障新兴科技的安全应用与可持续发展。更多还原

【Abstract】 Synthetic biology represents a typical representative paradigm merging engineering principles with life sciences, fundamentally reshaping global bio-security landscapes and ethical boundaries.However, rapid technological evolution has exposed structural lags in existing hard law frameworks, particularly regarding normative scope and institutional coordination.Consequently, international soft law has emerged as a critical mechanism that leverages agility and inclusivity to address the uncertainties of emerging technologies.Currently, diverse stakeholders, including international organizations and scientific communities, are constructing a multi-tiered soft law network.Through ethical guidelines and technical standards, this network effectively underpins risk assessment and the standardization of R&D conduct.Future governance must establish a composite system that dynamically couples soft and hard law.This approach leverages soft law for adaptive rule-making while anchoring hard law to enforce baseline obligations.Such a synergistic pathway fosters institutional integration, ensuring the safe and sustainable trajectory of emerging technologies.更多还原